General Information of Disease (ID: DIS8KHDE)

Disease Name Meningeal tuberculosis
Synonyms Meningitis, Tuberculous; tubercular meningitis; TBM; TB meningitis; tuberculous meningitis
Definition A bacterial infection of the membranes covering the brain and the spinal cord caused by Mycobacterium tuberculosis.
Disease Hierarchy
DISQABAA: Meningitis
DIS4OUTE: Central nervous system tuberculosis
DIS2YIMD: Tuberculosis
DISRP9SL: Bacterial meningitis
DISFW7FV: Tuberculous salpingitis
DIS8KHDE: Meningeal tuberculosis
Disease Identifiers
MONDO ID
MONDO_0006042
MESH ID
D014390
UMLS CUI
C0041318
MedGen ID
21725
Orphanet ID
499004
SNOMED CT ID
58437007

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Pyrazinamide DM4IF32 Approved Small molecular drug [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 5 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
LAMC2 TTNS7H3 Limited Biomarker [2]
ADA TTLP57V Strong Altered Expression [3]
HPD TT8DSFC Strong Biomarker [4]
LTA4H TTXZEAJ Strong Genetic Variation [5]
RNF34 TTEWDK1 Strong Biomarker [6]
------------------------------------------------------------------------------------
This Disease Is Related to 8 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
BBS9 OT23V9YF Limited Genetic Variation [7]
THEMIS OTXODBXJ moderate Biomarker [8]
ADSL OTSNJALL Strong Biomarker [9]
C1QTNF4 OTHD4Y9D Strong Altered Expression [10]
CCN6 OTRFHQ2Z Strong Biomarker [4]
NCAPG2 OTZYENKO Strong Biomarker [11]
RHOF OTPA3F8Q Strong Biomarker [6]
SIGLEC14 OT2JGGXD Definitive Genetic Variation [12]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 DOT(s)

References

1 Pyrazinamide FDA Label
2 Elevated Matrix Metalloproteinase Concentrations Offer Novel Insight Into Their Role in Pediatric Tuberculous Meningitis.J Pediatric Infect Dis Soc. 2020 Feb 28;9(1):82-86. doi: 10.1093/jpids/piy141.
3 Diagnostic Usefulness of Cytokine and Chemokine Levels in the Cerebrospinal Fluid of Patients with Suspected Tuberculous Meningitis.Am J Trop Med Hyg. 2019 Aug;101(2):343-349. doi: 10.4269/ajtmh.18-0947.
4 DNA polymorphism of Mycobacterium tuberculosis PE_PGRS33 gene among clinical isolates of pediatric TB patients and its associations with clinical presentation.Tuberculosis (Edinb). 2011 Jul;91(4):287-92. doi: 10.1016/j.tube.2011.05.001. Epub 2011 Jun 12.
5 Do Intracerebral Cytokine Responses Explain the Harmful Effects of Dexamethasone in Human Immunodeficiency Virus-associated Cryptococcal Meningitis?.Clin Infect Dis. 2019 Apr 24;68(9):1494-1501. doi: 10.1093/cid/ciy725.
6 Xpert MTB/RIF Ultra improved the diagnosis of paucibacillary tuberculosis: A prospective cohort study.J Infect. 2019 Apr;78(4):311-316. doi: 10.1016/j.jinf.2019.02.010. Epub 2019 Feb 21.
7 Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study.Lancet Infect Dis. 2018 May;18(5):526-535. doi: 10.1016/S1473-3099(18)30053-7. Epub 2018 Feb 3.
8 Evaluation of a New IFN- Release Assay for Rapid Diagnosis of Active Tuberculosis in a High-Incidence Setting.Front Cell Infect Microbiol. 2017 Apr 11;7:117. doi: 10.3389/fcimb.2017.00117. eCollection 2017.
9 Nucleotide degradation products in cerebrospinal fluid (CSF) in inherited and acquired pathologies.Nucleosides Nucleotides Nucleic Acids. 2004 Oct;23(8-9):1185-7. doi: 10.1081/NCN-200027451.
10 C1Q/TNF-related protein 4 expression correlates with herpes simplex encephalitis progression.Ann Transl Med. 2019 Jun;7(11):235. doi: 10.21037/atm.2019.05.01.
11 Diagnostic usefulness of Xpert MTB/RIF assay for detection of tuberculous meningitis using cerebrospinal fluid.J Infect. 2017 Aug;75(2):125-131. doi: 10.1016/j.jinf.2017.04.010. Epub 2017 May 10.
12 The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes.Tuberculosis (Edinb). 2017 May;104:38-45. doi: 10.1016/j.tube.2017.02.005. Epub 2017 Feb 21.